Compounds and compositions useful for treatment of proliferative disease or disorder
AssigneesUniversity of Houston System, Tract Pharmaceuticals, Inc.
InventorsWa Xian, Frank McKeon, Matthew Vincent, Richard E. Russell
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds, pharmaceutically acceptable compositions thereof and methods of using the same.
Claims33
A pharmaceutical composition comprising an IAP inhibitor and a cellular kinase inhibitor wherein the IAP inhibitor is a compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- L1 is a first ligand;
- L2 is a second ligand;
- and
- linker is a bivalent linker comprising
A combination comprising:
- an IAP inhibitor;
- and
- a cellular kinase inhibitor
- wherein the IAP inhibitor is a compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- L1 is a first ligand;
- L2 is a second ligand;
- and
- linker is a bivalent linker comprising
(canceled)
A method of treating a proliferative disorder comprising administering to a subject in need thereof combination therapy with an IAP inhibitor and a cellular kinase inhibitor
- wherein the IAP inhibitor is a compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- L1 is a first ligand;
- L2 is a second ligand;
- and
- linker is a bivalent linker comprising
(canceled)
(canceled)
(canceled)
-23. (canceled)
-36. (canceled)
-45. (canceled)
-50. (canceled)
A pharmaceutical composition comprising an IAP inhibitor for use in combination with a cellular kinase inhibitor
- wherein the IAP inhibitor is a compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- L1 is a first ligand;
- L2 is a second ligand;
- and
- linker is a bivalent linker comprising
Dependencies are inferred from the claim text.